SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
epi12564-sup-0001-Supporting Information.docxWord document299K

Data S1. Glossary: Definitions and abbreviations used throughout the document.

Table S1. Summary table of evidence regarding the association of HLA-B*15:02 with CBZ-induced SJS/TEN.

Table S2. Population frequencies of HLA-B*15:02.

Table S3. Summary table of evidence regarding the association of HLA-A*31:01 with CBZ-induced HSS and MPE.

Table S4. Summary table of evidence regarding the association of HLA-A*31:01 with CBZ-induced SJS/TEN.

Table S5. Population frequencies of HLA-A*31:01.

epi12564-sup-0002-Carbamazepine.pdfapplication/PDF136K

Data S2. Supplementary methods: Additional details on the evidence review and clinical practice recommendation development, including the systematic literature search strategy.

Data S3. Test availability: A brief discussion of test availability for HLA-B*15:02 and HLA-A*31:01.

Data S4. Quick reference document: Summary of key messages and recommendations in bullet point format.

epi12564-sup-0003-EPI.pptxapplication/pptx299K 

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.